Eureka, MO, United States of America

Russell David Odegard

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Russell David Odegard: Innovator in Pharmaceutical Analysis

Introduction

Russell David Odegard is a notable inventor based in Eureka, MO (US). He has made significant contributions to the field of pharmaceutical analysis, particularly in the development of methods for assessing the potency and purity of pharmaceutical compounds. With a total of 2 patents to his name, Odegard's work is paving the way for advancements in real-time analysis of pharmaceutical samples.

Latest Patents

Odegard's latest patents include an "On-site method of providing analysis of potency and purity of pharmaceutical compounds." This innovative approach utilizes a computer-facilitated method to request a spectral analysis of a sample with unknown concentration or purity. The process involves performing an energy absorption analysis to obtain spectral data, which is then compared to stored data to determine the sample's concentration or purity. Notably, this analysis can be conducted on-site using a portable analytical apparatus, allowing for real-time reporting of results with minimal sample size requirements.

Another significant patent is the "Interactive method of providing analysis of potency and purity of pharmaceutical compounds." This method enhances the user experience by allowing electronic requests for spectrographic analysis. The requester can monitor the progress of the analysis, and results are transmitted electronically in real time, ensuring efficient communication and timely access to critical data.

Career Highlights

Russell David Odegard is currently associated with Medpro Holdings, LLC, where he continues to innovate in the pharmaceutical sector. His work focuses on improving the accuracy and efficiency of pharmaceutical analysis, which is crucial for ensuring the safety and efficacy of medications.

Collaborations

Odegard has collaborated with notable colleagues, including Earl Michael Pruett and John H Coates. These partnerships have likely contributed to the development and refinement of his innovative methods in pharmaceutical analysis.

Conclusion

Russell David Odegard's contributions to the field of pharmaceutical analysis through his patents demonstrate his commitment to advancing healthcare technology. His innovative methods are set to enhance the accuracy and efficiency of drug analysis, ultimately benefiting the pharmaceutical industry and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…